A study conducted by the Department of Veterans Affairs, National Institutes of Health and the medical department at Stanford University could lead to groundbreaking treatment of cardiovascular disease and diabetes. The study identified ‘three genetic mutations that govern cholesterol levels.” Scientists could use the information to develop new drugs to treat the illnesses, according to VA.